1. Framingham score and microalbuminuria: Combined future targets for primary prevention? 
Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst 
Kidney International 
Volume 66, Pages S111-S114 (November 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan-Meier analysis illustrating the prognostic value of Framingham risk score in microalbuminuric subjects. The population is divided in three groups according to 10-year risk on cardiovascular disease. Hazard ratios (95% CIs) are given for the groups with a score between 10% to 20% and >20%.
Kidney International  , S111-S114DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
The effects of fosinopril and pravastatin on the calculated Framingham risk score and the observed incidence of cardiovascular events during four years of follow-up.
Kidney International  , S111-S114DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions